Dikicier S, Dikicier E, Karacayli U, Erguder B. Radiodensitometric study for evaluation of bone mineral density around dental implants after zoledronic acid treatment in ovariectomized rats. Med Oral Patol Oral Cir Bucal. 2017 May 1;22 (3):e377-82. 

 

 

doi:10.4317/medoral.21706

http://dx.doi.org/doi:10.4317/medoral.21706

 

 

1. G—mez-de Diego R, Mang-de la Rosa Mdel R, Romero-PŽrez MJ, Cutando-Soriano A, L—pez-Valverde-Centeno A. Indications and contraindications of dental implants in medically compromised patients: Update. Med Oral Patol Oral Cir Bucal. 2014;19:483-9.
https://doi.org/10.4317/medoral.19565

 

2. Giro G, Gonalves D, Sakakura CE, Pereira RM, Marcantonio Jœnior E, Orrico SR. Influence of estrogen deficiency and its treatment with alendronate and estrogen on bone density around osseointegrated implants: radiographic study in female rats. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;105:162-7.
https://doi.org/10.1016/j.tripleo.2007.06.010

 

3. Tresguerres IF, Clemente C, Donado M, G—mez-Pellico L, Blanco L, Alobera MA, et al. Local administration of growth hormone enhances periimplant bone reaction in an osteoporotic rabbit model. Clin Oral Implants Res. 2002;13:631-6.
https://doi.org/10.1034/j.1600-0501.2002.130609.x

 

4. Narai S, Nagata S. Effect of alendronate on the removal torque of implants in rats with induced osteoporosis. Int J Oral Maxillofac Implants. 2003;18:218-23.

 

5. Otto S, Schreyer C, Hafner S, et al. Bisphosponate-related osteonecrosis of the jaws-characteristics, risk factors, clinical features, and impact on oncological treatment. J Craniomaxillofacial Surg. 2012;40:303-9.
https://doi.org/10.1016/j.jcms.2011.05.003

 

6. Otto S, Schreyer C, Hafner S, Mast G, Ehrenfeld M, StŸrzenbaum S, et al. Effect of combined local treatment with zoledronic acid and basic fibroblast growth factor on implant fixation in ovariectomized rats. Bone. 2009;44:225-32.
https://doi.org/10.1016/j.bone.2008.10.054

 

7. Javed F, Almas K Osseointegration of dental implants in patients undergoing bisphosphonate treatment: a literature review. J Periodontol. 2010;8:479-84.
https://doi.org/10.1902/jop.2009.090587

 

8. Viera-Negr—n YE, Ruan WH, Winger JN, Hou X, Sharawy MM, Borke JL. Effect of ovariectomy and alendronate on implant osseointegration in rat maxillary bone. J Oral Implantol. 2008;34:76-82.
https://doi.org/10.1563/1548-1336(2008)34[76:EOOAAO]2.0.CO;2

 

9. Yildiz A, Esen E, KŸrkŸ M, Damlar I, Dağlioğlu K, Akova T. Effect of zoledronic acid on osseointegration of titanium implants: an experimental study in an ovariectomized rabbit model. J Oral Maxillofac Surg. 2010;68:515-23.
https://doi.org/10.1016/j.joms.2009.07.066

 

10. Qi M, Hu J, Li J, Li J, Dong W, Feng X, et al. Effect of zoledronate acid treatment on osseointegration and fixation of implants in autologous iliac bone grafts in ovariectomized rabbits. Bone. 2012;50:119-27.
https://doi.org/10.1016/j.bone.2011.10.011

 

11. Yao W, Cheng Z, Koester KJ, Ager JW, Balooch M, Pham A, et al. The degree of bone mineralization is maintained with single intravenous bisphosphonates in aged estrogen-deficient rats and is a strong predictor of bone strength. Bone. 2007;41:804-12.
https://doi.org/10.1016/j.bone.2007.06.021

 

12. Pyo SW, Kim YM, Kim CS, Lee IS, Park JU, et al. Bone formation on biomimetic calcium phosphate-coated and zoledronate-immobilized titanium implants im osteoporotic rat tibiae. Int J Oral Maxillofac Implants. 2014; 29:478-84.
https://doi.org/10.11607/jomi.3423

 

13. Stokholm R, Spin-Neto R, Nyengaard JR, Isidor F. Comparison of radiographic and histological assessment of peri-implant bone around dental implants. Clin Oral Implants Res. 2016;27:782-6.
https://doi.org/10.1111/clr.12683

 

14. Clokie CM, Warshawsky H. Morphologic and radioautographic studies of bone formation in relation to titanium implants using the rat tibia as a model. Int J Oral Maxillofac Implants. 1995;10:155-65.

 

15. Sakakura CE, Giro G, Gonalves D, et al. Radiographic assesment of bone density around integrated titanium implants after ovariectomy in rats. Clin Oral Impl Res. 2006;17:134-8.
https://doi.org/10.1111/j.1600-0501.2005.01224.x

 

16. Biasotto M, Chiandussi S, Zacchigna S, Moimas S, Dore F, Pozzato G, et al. A novel animal model to study non-spontaneous bisphosphonates osteonecrosis of jaw. J Oral Pathol Med. 2010;39:390-6.
https://doi.org/10.1111/j.1600-0714.2009.00878.x

 

17. Kurth AH, Eberhardt C, MŸller S, Steinacker M, Schwarz M, Bauss F. The bisphosphonate ibandronate improves implant integration in osteopenic ovariectomized rats. Bone. 2005;37:204-10.
https://doi.org/10.1016/j.bone.2004.12.017

 

18. Lugero GG, de Falco Caparbo V, Guzzo ML, Kšnig B Jr, Jorgetti V. Histomorphometric evaluation of titanium implants in osteoporotic rabbits. Implant Dent. 2000;9:303-9.
https://doi.org/10.1097/00008505-200009040-00005

 

19. Qi MC, Zhou XQ, Hu J, Du ZJ, Yang JH, Liu M, et al. Oestrogen replacement therapypromotes bone healing around dental implants in osteoporotic rats. Int J Oral Maxillofac Surg. 2004;33:279-85.
https://doi.org/10.1006/ijom.2002.0398

 

20. Durie BG, Katz M, Crowley J. Osteonecrosis of the jaw and bisphosphonates. N Engl J Med. 2005;353:99-102.
https://doi.org/10.1056/NEJM200507073530120

 

21. Bobyn JD, Hacking SA, Krygier JJ, Harvey EJ, Little DG, Tanzer M. Zoledronic acid causes enhancement of bone growth into porous implants. J Bone Joint Surg Br. 2005;87:416-20.
https://doi.org/10.1302/0301-620X.87B3.14665

 

22. Lespessailles E, JaffrŽ C, Beaupied H, Nanyan P, DollŽans E, Benhamou CL, et al. Does exercise modify the effects of zoledronic acid on bone mass, microarchitecture, biomechanics, and turnover in ovariectomized rats? Calcif Tissue Int. 2009;85:146-57.
https://doi.org/10.1007/s00223-009-9269-z

 

23. Brouwers JE, Lambers FM, Gasser JA, van Rietbergen B, Huiskes R. Bone degeneration and recovery after early and late bisphosphonate treatment of ovariectomized wistar rats assessed by in vivo micro-computed tomography. Calcif Tissue Int. 2008;82:202-11.
https://doi.org/10.1007/s00223-007-9084-3

 

24. Zuffetti F, Bianchi F, Volpi R, Trisi P, Del Fabbro M, Capelli M, et al. Clinical application of bisphosphonates in implant dentistry: histomorphometric evaluation. Int J Periodontics Restorative Dent. 2009;29:31-9.

 

25. Dikicier E, Karaaylġ †, Dikicier S, GŸnaydġn Y. Effect of systemic administered zoledronic acid on osseointegration of a titanium implant in ovariectomized rats. J Craniomaxillofac Surg. 2014;42:1106-11.
https://doi.org/10.1016/j.jcms.2014.01.039

 

26. Pan B, Farrugia AN, To LB, Findlay DM, Green J, Lynch K, et al. The nitrogen-containing bisphosphonate, zoledronic acid, influences RANKL expression in human osteoblast-like cells by activating TNF-alpha converting enzyme (TACE). J Bone Miner Res. 2004;19:147-54.
https://doi.org/10.1359/jbmr.2004.19.1.147

 

27. Pan J, Shirota T, Ohno K, Michi K. Effect of ovariectomy on bone remodeling adjacet to hydroxyapatite-coated implants in the tibia of mature rats. J Oral Maxillofac Surg. 2000;58:877-82.
https://doi.org/10.1053/joms.2000.8212

 

28. Grant BT, Amenedo C, Freeman K, Kraut RA. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases. J Oral Maxillofac Surg. 2008;66:223-30.
https://doi.org/10.1016/j.joms.2007.09.019

 

29. Bag‡n J, Blade J, Cozar JM, Constela M, Garc’a Sanz R, G—mez Veiga F, et al. Recommendations for the prevention, diagnosis and treatment of osteonecrosis of the jaw (ONJ) in cancer patients treated with bisphosphonates. Med Oral Patol Oral Cir Bucal. 2007;12:336-40.

 

30. Kos M, Kuebler JF, Luczak K, Engelke W. Bisphosphonate-related osteonecrosis of the jaws: a review of 34 cases and evaluation of risk. J Craniomaxillofacial Surg. 2010;38:255-9.
https://doi.org/10.1016/j.jcms.2009.06.005